Why the study?
Does the extent and location of late gadolinium enhancement on CMR correlate with left ventricular function in patients with cardiac sarcoidosis?
Population
n=19 patients with cardiac sarcoidosis diagnosed according to the 2006 revised guidelines of the Japanese…
Design
Cohort
Authors
Loading...
LGE extent was associated with impaired LV function in cardiac sarcoidosis; leaves open its prognostic value and role in management.
Does the extent and location of late gadolinium enhancement on CMR correlate with left ventricular function in patients with cardiac sarcoidosis?
The extent of late gadolinium enhancement on CMR correlates significantly with reduced left ventricular ejection fraction and increased LV diastolic volumes in patients with cardiac sarcoidosis.
Watanabe et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: